The Western Blot Learning center provides comprehensive resources, information, and guidance to help researchers improve their experimental western blotting approaches to obtain high-quality data.
Bio-Rad will chair a panel session that focuses on the current therapeutic landscape of SARS-CoV-2, the virus associated with COVID-19, and how the pandemic is in many ways transforming global medical research.
Bio-Rad awarded 25 scholarships to U.S. high school and undergraduate teachers from underrepresented communities to attend the National Science Teaching Association (NSTA) virtual conference, NSTA Engage: Fall20.
The kit provides a way for researchers to obtain highly sensitive and reproducible results.
The PCR systems represent the next generation of Bio-Rad’s CFX Real-time PCR products that are used in research and genomic testing as well pathogen detection and infectious disease testing.
More than 45 abstracts were presented showing the value of Droplet Digital PCR (ddPCR) technology as a tool for quantifying cancer biomarkers
Bio-Rad continues to support the worldwide effort to fight SARS-CoV-2, the virus associated with COVID-19 disease, offering instruments, tests, and a SARS-CoV-2 standard to help labs validate COVID-19 assay results.
Bio-Rad Laboratories Inc. announced that its CFX96 Dx Real-Time PCR System has been listed with the U.S. Food and Drug Administration (FDA) for IVD testing and may be used to help in the diagnosis of COVID-19.
Out of the Blue CRISPR and Genotyping Extension kits awarded “Best New Technology Innovation for Science” and the Science of Opioid Dependence Kit won in the category of “Best Tried & True Technology Teaching and
The latest imaging system from Bio-Rad’s GelDoc product line, offers sensitivity, performance, and reliability in a compact system.